[{"Assets_0_Q3_USD":484784000.0,"CommonStockSharesOutstanding_0_Q3_shares":78521438.0,"EarningsPerShareBasic_1_Q3_USD":0.44,"EarningsPerShareBasic_3_Q3_USD":-0.05,"EarningsPerShareDiluted_1_Q3_USD":0.44,"EarningsPerShareDiluted_3_Q3_USD":-0.05,"NetIncomeLoss_1_Q3_USD":33959000.0,"NetIncomeLoss_3_Q3_USD":-3293000.0,"StockholdersEquity_0_Q3_USD":131021000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":76888.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":66122.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":76887.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":66122.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]